St. Denis J. Villere & Co’s Bristol-Myers Squibb BMY Stock Holding History

St. Denis J. Villere & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,500	Closed	-$269K	–	62
2022 Q2	$269K	Sell	3,500 -186	-5%	-$14.2K	0.02%	53
2022 Q1	$269K	Buy	3,686 +386	+12%	+$25.9K	0.02%	56
2021 Q4	$205K	Buy	+3,300	New	+$194K	0.01%	61
2018 Q2	–	Sell	-4,650	Closed	-$294K	–	51
2018 Q1	$294K	Sell	4,650 -350	-7%	-$22.5K	0.02%	48
2017 Q4	$306K	Sell	5,000 -300	-6%	-$18.8K	0.02%	48
2017 Q3	$337K	Buy	+5,300	New	+$309K	0.02%	56

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

St. Denis J. Villere & Co's BMY Position: Q3 2022 in Review

St. Denis J. Villere & Co sold out of Bristol-Myers Squibb (BMY) in Q3 2022, closing a stake of 3,500 shares — an estimated $269K sold.

St. Denis J. Villere & Co first reported a position in BMY in Q3 2017 and held it in 6 quarters. The position peaked at $337K in Q3 2017. 2,469 funds tracked by Wall St. Rank hold BMY as of Q3 2022.

St. Denis J. Villere & Co reported no remaining Bristol-Myers Squibb position as of Q3 2022 after selling out during the quarter.
St. Denis J. Villere & Co sold 3,500 Bristol-Myers Squibb shares in Q3 2022, an estimated $269K.
St. Denis J. Villere & Co first reported a position in Bristol-Myers Squibb in Q3 2017 and held it in 6 quarters.
St. Denis J. Villere & Co's Bristol-Myers Squibb position peaked at $337K in Q3 2017.
2,469 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2022.

Based on St. Denis J. Villere & Co's 13F filing for Q3 2022, filed 17 Oct 2022.